Acadia Healthcare (ACHC) Stock Price, News & Analysis

Company Overview

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) is a provider of behavioral healthcare services. The company operates a network of psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics that provide care for individuals with mental health conditions, substance use disorders and other behavioral health needs.

Acadia’s services are designed for children, adolescents and adults and may include inpatient psychiatric treatment, addiction treatment, residential care, partial hospitalization and intensive outpatient programs. Its facilities address conditions such as depression, anxiety, trauma-related disorders, eating disorders and substance dependence.

Founded in 2005 and headquartered in Franklin, Tennessee, Acadia has expanded through the development and acquisition of behavioral healthcare facilities. The company primarily serves communities across the United States through facilities located in numerous states, offering treatment through both hospital-based and outpatient settings.

Key Stats

• Today's Range: $28.31 to $29.45
• 50-Day Range: $26.93 to $32.24
• 52-Week Range: $11.43 to $35.83
• Volume: 1.38 million shs
• Average Volume: 1.53 million shs
• Market Capitalization: $2.72 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $30.69
• Consensus Rating: Hold

Acadia Healthcare Stock Analysis - MarketRank™

Acadia Healthcare scored higher than 30% of companies evaluated by MarketBeat, and ranked 772nd out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.6 / 5
• Analyst Rating: Hold

Consensus Rating

Acadia Healthcare has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 8 buy ratings, 5 hold ratings, and 2 sell ratings.

Upside/Downside

The consensus price target for Acadia Healthcare is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Acadia Healthcare has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 14.84%

Earnings Growth

Earnings for Acadia Healthcare are expected to grow by 14.84% in the coming year, from $1.55 to $1.78 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Acadia Healthcare is -2.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Acadia Healthcare is -2.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Acadia Healthcare has a PEG Ratio of 9.17. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Acadia Healthcare has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

24.76% of the float of Acadia Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Acadia Healthcare has a short interest ratio ("days to cover") of 13.91, which indicates bearish sentiment.

Change versus previous month

Short interest in Acadia Healthcare has recently increased by 5.86%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Acadia Healthcare does not currently pay a dividend.

Dividend Growth

Acadia Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.79

News Sentiment

Acadia Healthcare has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Acadia Healthcare this week, compared to 7 articles on an average week.

MarketBeat Follows

Only 1 people have added Acadia Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Acadia Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.20% of the stock of Acadia Healthcare is held by insiders.

Percentage Held by Institutions

Acadia Healthcare has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/28/2026
• Today: 10/10/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NASDAQ:ACHC
• CIK: 1520697
• Web: www.acadiahealthcare.com
• Phone: (615) 861-6000
• Fax: 615-261-9685
• Employees: 25,000
• Year Founded: 2005

Price Target and Rating

• Average Price Target for Acadia Healthcare: $30.69
• High Price Target: $40.00
• Low Price Target: $13.00
• Potential Upside/Downside: +4.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.40
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): ($12.45)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 18.87
• P/E Growth: 9.17
• Net Income: -$1.10 billion
• Net Margins: -33.44%
• Pretax Margin: -32.56%
• Return on Equity: 6.19%
• Return on Assets: 2.42%

Debt

• Debt-to-Equity Ratio: 1.20
• Current Ratio: 1.57
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $3.31 billion
• Price / Sales: 0.82
• Cash Flow: $4.20 per share
• Price / Cash Flow: 6.97
• Book Value: $21.12 per share
• Price / Book: 1.38

Miscellaneous

• Outstanding Shares: 93,100,000
• Free Float: 91,983,000
• Market Cap: $2.72 billion
• Optionable: Optionable
• Beta: 0.63